Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-α production in injured spinal cord and in activated microglia via a cAMP-dependent pathway

Journal of Neuroscience

Volumn 20, Issue 10, 2000, Pages 3622-3630

  Kim, Woong Ki ^a   Kan, Yanqing ^a   Ganea, Doina ^a   Hart, Ronald P ^a   Gozes, Illana ^b   Jonakait, G Miller ^a  

^a RUTGERS UNIVERSITY   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CAMP; LPS; PACAP; PKA; Spinal cord injury; TNF microglia; VIP

Indexed keywords

CELL RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HORMONE BINDING; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPINAL CORD INJURY;

EID: 0034658528     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-10-03622.2000     Document Type: Article

References (85)

1. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153:801-813.
2. Albrecht H, Schook LB, Jongeneel CV (1995) Nuclear migration of NF-κB correlates with TNF-α mRNA accumulation. J Inflamm 45:64-71.
3. 2+ accumulation. Proc Natl Acad Sci USA 92:9328-9332.
4. Bartholdi D, Schwab ME (1997) Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9:1422-1438.
5. Boudard F, Bastide M (1991) Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J Neurosci Res 29:29-41.
6. Breder CD, Dinarello CA, Saper CB (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240:321-324.
7. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB (1993) Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J Comp Neurol 337:543-567.
8. Brenneman DE, Eiden LE, Siegel RE (1985) Neurotrophic action of VIP on spinal cord cultures. Peptides 6(Suppl 2):35-39.
9. Bruccoleri A, Brown H, Harry GJ (1998) Cellular localization and temporal elevation of tumor necrosis factor-α, interleukin-1α, and transforming growth factor-β1 mRNA in hippocampal injury response induced by trimethyltin. J Neurochem 71:1577-1587.
10. Campard PK, Crochemore C, Rene F, Monnier D, Koch B, Loeffler JP (1997) PACAP type 1 receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol 16:323-333.
11. Chao CC, Hu S (1994) Tumor necrosis factor-α potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 16:172-179.
12. Chao CC, Hu X, Sheng WS, Peterson PK (1995) Tumor necrosis factor-α production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 17:97-105.
13. Cheepsunthorn P, Heyliger SO, Connor JR (1999) Characterization of novel brain-derived microglial cell line isolated from neonatal rat brain. Soc Neurosci Abstr 25:203.7.
14. Cheng B, Christakos S, Mattson MP (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139-153.
15. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
16. de Bock F, Derijard B, Dornand J, Bockaert J, Rondouin G (1998) The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-α. Eur J Neurosci 10:3107-3114.
17. Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D (1998) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor-α transcriptional activation by regulating nuclear factor-κB and cAMP response element-binding protein/c-Jun. J Biol Chem 273:31427-31436.
18. Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP (1999a) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies. J Immunol 162:2358-2367.
19. Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP (1999b) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J Immunol 162:1200-1205.
20. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999c) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 162:1707-1716.
21. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999d) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and IFN regulatory factor 1 activation. J Immunol 162:4685-4696.
22. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999c) VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T-cells. J Neuroimmunol 96:167-181.
23. Dickinson T, Fleetwood-Walker SM (1999) VIP and PACAP: very important in pain? Trends Pharmacol Sci 20:324-329.
24. D'Souza SD, Bonnetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996) Multiple sclerosis: fas signaling in oligodendrocyte death. J Exp Med 184:2361-2370.
25. Feuerstein GZ, Liu T, Barone FC (1994) Cytokines, inflammation, and brain injury: role of tumor necrosis factor-α. Cerebrovasc Brain Metab Rev 6:341-360.
26. Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhurst S, Gelbard HA (1996) Tumor necrosis factor-α inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 271:15303-15306.
27. Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults and amyloid β-peptide toxicity. J Neurochem 66:869-872.
28. Gozes I, Lilling G, Glazer R, Ticher A, Ashkenazi IE, Davidson A, Rubinraut S, Fridkin M, Brenneman DE (1995) Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J Pharmacol Exp Ther 273:161-167.
29. Hart RP, Li N, Yang L, Ramer MB, Huang W, Young W (1999) Early induction of cytokine mRNAs following spinal cord injury. Soc Neurosci Abstr 25:537.10.
30. Haviv R, Stein R (1999) Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 55:269-277.
31. Hayashi M, Ueyama T, Tamaki T, Senba E (1997) Expression of neurotrophin and IL-1β mRNAs following spinal cord injury and the effects of methylprednisolone treatment. Kaibogaku Zasshi 72:209-213.
32. Hisahara S, Shoji S, Okano H, Miura M (1997) ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 69:10-20.
33. Hyatt-Sachs H, Schreiber RC, Bennett TA, Zigmond RE (1993) Phenotypic plasticity in adult sympathetic ganglia in vivo: effects of deafferentation and axotomy on the expression of vasoactive intestinal peptide. J Neurosci 13:1642-1653.
34. Ichinose M, Sawada M, Maeno T (1994) Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages. Regul Pept 54:457-466.
35. Jonakait GM, Luskin MB, Wei R, Tian X-F, Ni L (1996) Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro. Dev Biol 177:85-95.
36. Jongeneel CV (1994) Regulation of the TNF-α gene. Prog Clin Biol Res 388:367-381.
37. Kita T, Liu L, Tanaka N, Kinoshita Y (1997) The expression of tumor necrosis factor-α in the rat brain after fluid percussive injury. Int J Legal Med 110:305-311.
38. Klimaschewski L, Unsicker K, Heym C (1995) Vasoactive intestinal peptide but not galanin promotes survival of neonatal rat sympathetic neurons and neurite outgrowth of PC12 cells. Neurosci Lett 195:133-136.
39. Klimaschewski L, Grohmann I, Heym C (1996) Target-dependent plasticity of galanin and vasoactive intestinal peptide in the rat superior cervical ganglion after nerve lesion and re-innervation. Neuroscience 72:265-272.
40. Klusman I, Schwab ME (1997) Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 762:173-184.
41. Kong LY, Maderdrut JL, Joehn GH, Hong JS (1999) Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 91:493-500.
42. Lafortune L, Nalbantoglu J, Antel JP (1996) Expression of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol 55:515-521.
43. Laskin DL, Pendino KJ (1995) Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35:655-677.
44. Lee SC, Liu W, Dickson DW. Brosnan CF, Berman JW (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β. J Immunol 150:2659-2667.
45. Liu T, Clark RK, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481-1488.
46. Martinez C, Delgado M, Gomariz RP, Ganea D (1996) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T-lymphocytes. J Immunol 156:4128-4136.
47. Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP (1998) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J Leukoc Biol 63:591-601.
48. Mattson MP, Cheng B, Baldwin SA, Smith-Swintosky VL, Keller J, Geddes JW, Scheff SW, Christakos S (1995) Brain injury and tumor necrosis factors induce calhindin D-28k in astrocytes: evidence for a cytoprotective response. J Neurosci Res 42:357-370.
49. Moller K, Reimer M, Hannibal J, Fahrenkrug J, Sundler F, Kanje M (1997) Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro. Brain Res 775:156-165.
50. New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA (1998) HIV-1 Tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NF-κB-independent mechanism. J Biol Chem 273:17852-17858.
51. Ollivier V, Parry GCN, Cobb RR, de Prost D, Mackman N (1996) Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271:20828-20835.
52. Parry GC, Mackman N (1997) Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J Immunol 159:5450-5456.
53. Rao MS, Sun Y, Vaidyanathan U, Landis SC, Zigmond RE (1993) Regulation of substance P is similar to that of vasoactive intestinal peptide after axotomy or explantation of the rat superior cervical ganglion. J Neurobiol 24:571-580.
54. Sawada M, Kondo N, Suzumura A, Marunouchi T (1989) Production of tumor necrosis factor-α by microglia and astrocytes in culture. Brain Res 491:394-397.
55. Scherbel U, Raghupathi R, Nakamura M, Saatman KE, Trojanowski JQ, Neugehauer E, Marino MW, McIntosh TK (1999) Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci USA 96:8721-8726.
56. Schwartz M, Solomon A, Lavie V, Ben-Bassat S, Belkin M, Cohen A (1991) Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res 545:334-338.
57. Sébire G, Emilie D, Wallon C, Héry C, Devergne O, Delfraissy JF, Galanaud P, Tardieu M (1993) In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 150:1517-1523.
58. Selmaj K, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
59. Selmaj K, Shafit-Zagardo B, Aquino DA, Farooq M, Raine CS, Norton WT, Brosnan CF (1991) Tumor necrosis factor-induced proliferation of astrocytes from mature brain is associated with down-regulation of glial fibrillary acidic protein mRNA. J Neurochem 57:823-830.
60. Sharif SF, Hariri RJ, Chang VA, Barie PS, Wang RS, Ghajar JB (1993) Human astrocyte production of tumor necrosis factor-α, interleukin-1β, and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neurol Res 15:109-112.
61. Shehab SA, Atkinson ME (1986) Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons. Brain Res 372:37-44.
62. Sheng WS, Hu S, Kravitz FH, Peterson PK, Chao CC (1995) Tumor necrosis factor-α upregulates human microglial cell production of interleukin-10 in vitro. Clin Diagn Lab Immunol 2:604-608.
63. Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF-α and IL-6 by brain tissue. J Cereb Blood Flow Metab 14:615-619.
64. Shohami E, Bass R, Wallach D, Yamin A, Gallily R (1996) Inhibition of tumor necrosis factor-α (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 16:378-384.
65. Sirianni MC, Annibale B, Tagliaferri F, Fais S, De Luca S, Pallone F, Delle Fave G, Aiuti F (1992) Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon, and GHRF specifically inhibit NK activity. Regul Pept 38:79-87.
66. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT (1998) Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152:74-87.
67. Sullivan PG, Bruce-Keller AJ, Ranchevsky AG, Christakos S, St. Clair DK, Mattson MP, Scheff SW (1999) Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 19:6248-6256.
68. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE, Gelbard HA (1995) Tumor necrosis factor α-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 15:2359-2366.
69. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, Tohyama M (1999) Tumor necrosis factor induces bcl-2 and bcl-x expression through NF-κB activation in primary hippocampal neurons. J Biol Chem 274:8531-8538.
70. Tang H, Welton A, Ganea D (1995) Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553. J Interferon Cytokine Res 15:993-1003.
71. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M (1997) Induction of tumor necrosis factor-α in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 17:491-499.
72. Vastag M, Skopal J, Voko Z, Csonka E, Nagy Z (1999) Expression of membrane-bound and soluble cell adhesion molecules by human brain microvessel endothelial cells. Microvasc Res 57:52-60.
73. Viviani B, Corsini E, Galli CL, Marinovich M (1998) Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-α. Toxicol Appl Pharmacol 150:271-276.
74. Wang CX, Nuttin B, Heremans H, Dom R, Gybels J (1996) Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol 69:151-156.
75. Wang CX, Olschowka JA, Wrathall JR (1997) Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 759:190-196.
76. Wang HY, Xin Z, Tang H, Ganea D (1996) Vasoactive intestinal peptide inhibits IL-4 production in murine T-cells by a post-transcriptional mechanism. J Immunol 156:3243-3253.
77. Wei R, Jonakait GM (1999) Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11, and transforming growth factor-β1 (TGF-β1) down-regulate T-cell costimulatory molecules B7 and CD40 on cultured rat microglia. J Neuroimmunol 95:8-18.
78. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A, Cuzner ML (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33:227-236.
79. Yakovlev AG, Faden AI (1994) Sequential expression of c-fos protooncogene, TNF-α, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol 23:179-190.
80. Yao J, Mackman N, Edgington TS, Fan ST (1997) Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1: c-Jun, and NF-κB transcription factors. J Biol Chem 272:17795-17801.
81. Zhang X, Verge VM, Wiesenfeld-Hallin Z, Piehl F, Hokfelt T (1993) Expression of neuropeptides and neuropeptide mRNAs in spinal cord after axotomy in the rat, with special reference to motoneurons and galanin. Exp Brain Res 93:450-461.
82. Zhang YZ, Hannibal J, Zhao Q, Moller K, Danielson N, Fahrenkrug J, Sundler F (1996) Pituitary adenylate cyclase-activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience 74:1099-1110.
83. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-κB is regulated by IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424.
84. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671.
85. Zhou X, Rodriguez WI, Casillas RA, Ma V, Tam J, Hu Z, Lelievre V, Chao A, Waschck JA (1999) Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. J Neurosci Res 57:953-961.